Genetic obesity syndromes

The Genetics of Obesity

Volumn , Issue , 2014, Pages 23-32

  Farooqi, I Sadaf ^a   O'Rahilly, Stephen ^a  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930246785     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-8642-8_2     Document Type: Chapter

References (34)

1. Goldstone AP (2004) Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 15:12-20.
2. Carrel AL, Allen DB (2001) Prader-Willi syndrome: how does growth hormone affect body composition and physical function? J Pediatr Endocrinol Metab 14(Suppl 6):1445-1451.
3. Haqq AM, Farooqi IS, ORahilly S et al (2003) Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174-178.
4. de Smith AJ, Purmann C, Walters RG et al (2009) A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum Mol Genet 18:3257-3265.
5. Sahoo T, del Gaudio D, German JR et al (2008) Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 40:719-721.
6. Weinstein LS, Chen M, Liu J (2002) Gs(alpha) mutations and imprinting defects in human disease. Ann N Y Acad Sci 968:173-197.
7. Ansley SJ, Badano JL, Blacque OE et al (2003) Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425:628-633.
8. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC (2009) Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet 18:1323-1331.
9. Yeo GS, Connie Hung CC, Rochford J et al (2004) A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 7:1187-1189.
10. Gray J, Yeo GS, Cox JJ et al (2006) Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55:3366-3371.
11. Han JC, Liu QR, Jones M et al (2008) Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med 359:918-927.
12. Holder JL Jr, Butte NF, Zinn AR (2000) Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet 9:101-108.
13. Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR (2008) Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol 22:1723-1734.
14. Huszar D, Lynch CA, Fairchild-Huntress V et al (1997) Targeted disruption of the melanocortin- 4. receptor results in obesity in mice. Cell 88:131-141.
15. Farooqi IS, Wangensteen T, Collins S et al (2007) Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356:237-247.
16. Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-1103.
17. Farooqi IS, Jebb SA, Langmack G et al (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-884.
18. Farooqi IS, Bullmore E, Keogh J, Gillard J, ORahilly S, Fletcher PC (2007) Leptin regulates striatal regions and human eating behavior. Science 317:1355.
19. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J (2008) Leptin reverses weight lossinduced changes in regional neural activity responses to visual food stimuli. J Clin Invest 118:2583-2591.
20. Krude H, Biebermann H, Schnabel D et al (2003) Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 88:4633-4640.
21. Challis BG, Pritchard LE, Creemers JW et al (2002) A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 11:1997-2004.
22. Lee YS, Challis BG, Thompson DA et al (2006) A POMC variant implicates beta-melanocytestimulating hormone in the control of human energy balance. Cell Metab 3:135-140.
23. Seidah NG (2011) The proprotein convertases, 20 years later. Methods Mol Biol 768:23-57.
24. Jackson RS, Creemers JW, Ohagi S et al (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene [see comments]. Nat Genet 16:303-306.
25. Jackson RS, Creemers JW, Farooqi IS et al (2003) Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 112:1550-1560.
26. Stutzmann F, Tan K, Vatin V et al (2008) Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 57:2511-2518.
27. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, ORahilly S (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085-1095.
28. Martinelli CE, Keogh JM, Greenfield JR et al (2011) Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab 96:E181-E188.
29. Greenfield JR, Miller JW, Keogh JM et al (2009) Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 360:44-52.
30. Hatoum IJ, Stylopoulos N, Vanhoose AM et al (2012) Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab 97:E1023-E1031.
31. Wheeler E, Huang N, Bochukova EG et al (2013) Genome-wide SNP and CNV analysis identifi es common and low-frequency variants associated with severe early-onset obesity. Nat Genet 45:513-517.
32. Bochukova EG, Huang N, Keogh J et al (2010) Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463:666-670.
33. Doche ME, Bochukova EG, Su HW et al (2012) Human SH2B1 mutations are associated with maladaptive behaviors and obesity. J Clin Invest 122:4732-4736.
34. Dietz WH, Robinson TN (2005) Clinical practice. Overweight children and adolescents. N Engl J Med 352:2100-2109.